Description

Please note: AABB reserves the right to make updates to this program.

Live Program Date: August 22, 2019
Master Program Number: 19EL-466

Educational Track: Technical/Clinical
Topic: Transfusion Medicine (Hemovigilance)
Intended Audience: Hospitals, Hospital Blood Banks, Laboratory Staff, Managers/Supervisors, Medical Directors, Nurses, Physicians, Research Scientists, Residents/Fellows, Scientists, Students (MD, MT, SBB)
Teaching Level: Basic to Intermediate

Director/Moderator: Chester Andrzejewski, MD, PhD, Medical Director, System Transfusion Medicine, Baystate Medical Center, Springfield, MA
Speakers: Nancy L. Van Buren, MD, Medical Director, Innovative Blood Resources, Saint Paul, MN; Stephanie Bates, MD, Assistant Professor, Medical Director of Transfusion Service, Coagulation Laboratory, HPC Processing Laboratory, University of Oklahoma Medical Center, Oklahoma City, OK

Learning Objectives
After participating in this educational activity, participants should be able to:

• Apply CDC National Healthcare Safety Network (NHSN) case definition criteria to identify adverse transfusion reactions through presented cases studies.
• Identify adverse transfusion reactions that need to be reported to blood centers for further investigation.
• Identify scenarios where donors might get deferred as a result of adverse transfusion reaction to patients.

Program Description: Diagnosing adverse transfusion reactions (ATR) is often challenging and complicated. Certain adverse reactions get reported to blood centers for further investigation. This program will present case studies that will help the audience understand the clinical signs and symptoms, lab works, vitals and investigations to diagnose and classify ATRs. The audience will also learn about workups that blood centers conduct to provide final diagnosis for certain ATRs.

How to Claim CE Credit

• Single Viewers: if you registered as a single viewer, complete the evaluation found on the "CE Information" tab after watching the video. By submitting the evaluation, you are attesting to watching the presentation in its entirety.

• Group Viewers: if your group/facility registered for group viewing for this on-demand eCast, you do not need to complete the evaluation on the "CE Information" tab. Group Viewing participants will be granted CE (if applicable) after viewing the presentation, completion of the attendance log with all requested information and Group Viewing Coordinators submission of the attendance log to AABB within 72 hours of the completion/viewing date. Group Viewing Coordinators should submit the completed attendance log to eLearning@aabb.org. Participants on the attendance log will receive via email a program evaluation to complete within 5-7 business days after AABB’s receipt of the attendance log. Continuing education credit certificates will be emailed to the participants with a copy to the Group Viewing Coordinator no sooner than 31 days but not longer than 6 weeks from the completion/viewing date

Director & Moderator(s):

• Dr. Chester Andrzejewski, Jr., PhD,MD,FCAP, Medical Director of System Transfuion Medicine, Baystate Health / Baystate Medical Center

Speaker(s):

• Dr. Nancy L. Van Buren, MD, Medical Director, Innovative Blood Resources, division of New York Blood Center
• Stephanie Bates, MD, Assistant Professor, Medical Director of Transfusion Service, Coagulation Laboratory, HPC Processing Laboratory, University of Oklahoma Medical Center